Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
My Bing
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
Trending on Bing
NBA Hall of Famer dies
Landslide buried 2K+ people
‘Whites only’ job posting fine
Drops dad's surname
Defends wife against trolls
Medical scare on flight
Rancher, 34 cattle killed
Applies for Polish citizenship
Apologizes to fans
Family: He died by suicide
On Democratic criticism
Iran uranium stockpile grows
Musk’s xAI raises $6B
KY state of emergency
Rafah attack 'tragic mistake'
Mount Ibu erupts again
Oil price surges
US: Weapons are coming
Hybrid version of 500 EV?
Libertarians nominate Oliver
Mass. stabbing suspect ID'd
Memorial Day 2024
Teen dead, 6 hurt in shooting
1st individual PGA Tour win
Adds three opening acts
US, Europe bird flu vaccine
Closing arguments Tuesday
Fined max amount for elbowing
Honors fallen US troops
Venus volcanically active
'Furiosa' claims No. 1 spot
To invest in Italy cloud plan?
CrowdTangle safety features
Nadal swept by Zverev
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Johnson & Johnson, Kenvue
J&J to exit spinoff Kenvue with latest stake sale
(Reuters) -Tylenol maker Kenvue said on Monday that Johnson & Johnson will sell its remaining 9.5% stake in the company, about a year after the healthcare conglomerate spun off and listed its consumer health business.
J&J to exit Kenvue, a year after spinoff
Tylenol maker Kenvue said on Monday that Johnson & Johnson will offload its entire 9.5% stake in the company, about a year after the healthcare conglomerate spun off and listed its consumer health business.
J&J to Sell Remaining Stake in Kenvue Spinoff
By Dean Seal Johnson & Johnson plans to unload its remaining 9.5% stake in Kenvue in a public offering set about a year after it started splitting
Johnson & Johnson brings in billions from remaining Kenvue stake
Johnson & Johnson has sold off its remaining stake in the Kenvue consumer products business it spun off last year.
J&J to sell rest of Kenvue stake for US$3.7bn
All websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser. You need to be a subscriber to view this content.
Johnson & Johnson is selling its remaining Kenvue shares
Johnson & Johnson is selling its remaining shares in Kenvue Inc., the consumer-health business that it spun out last year.
Johnson & Johnson Is Officially Getting Out of Kenvue (KVUE) Stock
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Kenvue (NYSE:KVUE) stock is in the news Monday after the company
J&J offloads US$3.65bn Kenvue stake in 2024's biggest stock sale
All websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Johnson & Johnson Will Sell Remaining Stake in Kenvue (NYSE:KVUE)
Kenvue (NYSE:KVUE) announced on Monday that Johnson & Johnson (NYSE:JNJ) will sell its remaining 9.5% stake in the consumer health company. This
Johnson & Johnson To Sell Entire Stake In Spin-Off Kenvue
Healthcare giant Johnson & Johnson (JNJ) plans to sell its entire stake in spun-off company Kenvue (KVUE). Johnson & Johnson currently holds 182.3 million shares in Kenvue stock. The company plans to sell the shares it owns in a debt-for-equity exchange.
5d
on MSN
Cancer victims sue J&J over 'fraudulent' bankruptcies
A group of cancer victims sued Johnson & Johnson on Wednesday, accusing the healthcare company of committing fraud through repeated and continued efforts to use a shell company's bankruptcy to resolve ...
14d
Kenvue Launches Secondary Offering Of 182.33 Mln Shares
Kenvue Inc. (KVUE), consumer health company, Monday announced launch secondary public offering of 182.33 million shares. The ...
KELO
16d
Sioux Falls drug dealer gets 20 year sentence
SIOUX FALLS, S.D. (KELO.com) — A Sioux Falls drug dealer will be off the streets for a long time. Jason Winckler, 44, was ...
FiercePharma
10d
UPDATED: GSK raises £1.25B through final Haleon share sale
Right on the heels of a similar move by Johnson & Johnson, GSK is offloading the rest of its stake in the consumer healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results